Should Health-Care Systems Pay for Replacement Therapy in Patients With α1-Antitrypsin Deficiency?

This publication has 19 references indexed in Scilit:

• Survival and FEV₁Decline in Individuals with Severe Deficiency of α₁-Antitrypsin
  American Journal of Respiratory and Critical Care Medicine, 1998
• Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group
  European Respiratory Journal, 1998
• Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group
  European Respiratory Journal, 1997
• Assessing the effectiveness of health interventions for cost-effectiveness analysis
  Journal of General Internal Medicine, 1997
• Clinical Features and Natural History of Severe α1-Antitrypsin Deficiency
  Chest, 1997
• Clinical Recommendations Using Levels of Evidence for Antithrombotic Agents
  Chest, 1995
• Replacement Therapy for Hereditary Alpha1-Antitrypsin Deficiency
  Chest, 1994
• Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease
  The American Journal of Medicine, 1988
• Replacement Therapy for Alpha₁-Antitrypsin Deficiency Associated with Emphysema
  New England Journal of Medicine, 1987
• The Electrophoretic α;₁-Globulin Pattern of Serum in α;₁-Antitrypsin Deficiency
  Scandinavian Journal of Clinical and Laboratory Investigation, 1963